Stay updated on Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.3.4 has replaced v3.3.3. This appears to be a backend version update with no visible changes to study details on the page.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe Locations section now lists Beijing Municipality and Shanghai Municipality under Locations, and the revision version updated to v3.3.3.SummaryDifference0.3%

- Check51 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed, a public database, and the revision note updates the page version from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check58 days agoChange DetectedThe government funding notice about potential delays and operating status has been removed from the page.SummaryDifference0.4%

- Check73 days agoChange DetectedCosmetic updates to layout and styling are visible, with no changes to core study information such as the title, conditions, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check102 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference3%

Stay in the know with updates to Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.